bryan johnson is an entrepreneur who built a payments company and now runs projects aimed at reversing aging while funding brain research and venture investments.
He founded Braintree, which bought a person-to-person payments app and later sold to PayPal, a deal that Time reported left him with more than $300 million.
Johnson used personal capital to launch OS Fund and Kernel, putting large sums into both ventures and backing neuroscience devices that record electrical and hemodynamic brain signals, as reported in his company materials.
He has promoted Project Blueprint, an intensive life extension regimen that includes a strict diet, sleep optimization, scans, tests, daily therapies, and, at one point, monthly plasma transfusions with his son as a donor, which Johnson later said showed no benefit.
The US Food and Drug Administration has said transfusions like those are without benefit and may be harmful, and Johnson’s regimen has drawn skepticism from scientists quoted in public reporting.
His public persona has grown through interviews and a documentary that chronicle his routine, including detailed sleep metrics and a regimented day of light exposure, exercise, and therapies described in reporting by Wired.
Kernel has demonstrated helmet-like devices intended to read brain activity and has raised outside funding after Johnson’s initial investments, according to company disclosures.
Controversies Reactions And Legal Developments
The New York Times reported that Johnson used confidentiality agreements widely and that some former workers have challenged those terms, a practice Johnson has defended on social media, according to his posts cited in reporting.
His former fiancée and ex-employee brought claims that proceeded through arbitration, and the arbitrator dismissed the employment-related claims while assigning legal fees, as reflected in coverage of the dispute.
Documents released by the Department of Justice, reported in media accounts, show that Johnson met and exchanged emails with Jeffrey Epstein about Kernel introductions; Johnson confirmed the meeting and said he ended contact after one video conference, according to those reports.
Journalists and longevity experts have both followed Johnson’s work closely, noting his public ambitions around artificial intelligence and a philosophy he has summarized as a refusal to die, while some scientists express skepticism about the ability of current science to deliver the outcomes he promotes.
Johnson continues to balance his public advocacy, product efforts tied to his Blueprint venture, and the scrutiny that comes with his high profile, as reflected in recent reporting.
